## Management of Indeterminate Nodule in Cirrhosis ### Diagnostic Uncertainty: The 1–2 cm Nodule Dilemma **Key Point:** A 1–2 cm nodule with APHE but WITHOUT washout in a cirrhotic liver is **indeterminate** — it does not meet diagnostic criteria for HCC on a single imaging study. The gold standard approach is **repeat imaging in 3–4 months** to document both APHE and washout, which would then confirm HCC diagnosis. ### AASLD/EASL Diagnostic Algorithm for Nodules in Cirrhosis | Nodule Size | Diagnostic Criteria | |---|---| | >2 cm | APHE + washout on ONE imaging modality (CT/MRI/US) = HCC | | 1–2 cm | **Both** APHE + washout on ONE modality, **OR** APHE on one modality + AFP >400 ng/mL = HCC | | <1 cm | Surveillance every 3 months; biopsy if growth | **Clinical Pearl:** In this case, the nodule shows only APHE without washout, and AFP is 85 ng/mL (not >400). This is **not diagnostic** for HCC on current imaging. Repeat imaging in 3–4 months is standard practice to: 1. Confirm persistence of the nodule 2. Document washout (if present, confirms HCC) 3. Assess for growth (growth favors malignancy) ### Why NOT Biopsy? **High-Yield:** Biopsy is contraindicated in suspected HCC because: - Risk of tumor seeding along needle tract - Diagnostic criteria (imaging + AFP) are sufficient; biopsy is not required - Biopsy may be falsely negative (sampling error in small nodules) - Bleeding risk in cirrhotic patients with coagulopathy ### Why NOT Immediate Treatment? Sorafenib and resection/transplantation are reserved for **confirmed HCC**. This nodule is still indeterminate; premature treatment of a benign or dysplastic nodule is inappropriate. **Mnemonic:** **APHE + Washout = HCC**; APHE alone = **Indeterminate, Repeat**. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.